Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy source : Ir.vtvtherapeutics.com save search
vTv Therapeutics Presents Two Late-Breaking Poster Sessions on Simplici-T1 Study at the American Diabetes Association’s Virtual Sessions Supporting the Potential of TTP399 as First-in-Class Oral Adjunctive Therapy for Type 1 Diabetes Patients
Published: 2020-06-13 (Crawled : 14:47) - ir.vtvtherapeutics.com
VTVT | $25.39 1.66% 1.63% 4.2K
|
Health Technology
| Email alert
Add to watchlist
diabetes therapy ttp399 potential
vTv Therapeutics to Present Additional Positive Clinical Study Results from Phase 2 Simplici-T1 Study of TTP399 as Adjunctive Therapy for Patients with Type 1 Diabetes at EASD Virtual Meeting
Published: 2020-09-16 (Crawled : 14:47) - ir.vtvtherapeutics.com
VTVT | $25.39 1.66% 1.63% 4.2K
|
Health Technology
|
| O: 4.1%
H: 4.43%
C: 0.49%
diabetes therapy positive results phase 2 ttp399
vTv Therapeutics Presents Additional Positive Clinical Study Results Supporting the Safety and Efficacy of TTP399 as Adjunctive Therapy in Patients with Type 1 Diabetes
Published: 2020-09-23 (Crawled : 14:47) - ir.vtvtherapeutics.com
VTVT | $25.39 1.66% 1.63% 4.2K
|
Health Technology
|
| O: 12.3%
H: 2.86%
C: -13.81%
diabetes therapy positive results ttp399
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.